Thomas Jensen
Fondatore presso ALLARITY THERAPEUTICS, INC.
Patrimonio netto: - $ in data 30/06/2024
Provenienza dei contatti di primo grado di Thomas Jensen
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.
22
| Private Company | Pharmaceuticals: Major | 22 |
| Public Company | Pharmaceuticals: Major | 14 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Thomas Jensen tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Allarity Therapeutics Europe ApS
 Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark. | Pharmaceuticals: Major | Chairman Chief Executive Officer Founder Chief Operating Officer Director/Board Member Corporate Officer/Principal | |
| Copenhagen Business School | College/University | Graduate Degree Masters Business Admin Graduate Degree Undergraduate Degree | |
| CHOSA ONCOLOGY AB | Miscellaneous Commercial Services | Chief Executive Officer Chief Operating Officer Director/Board Member | |
Oncology Venture US, Inc.
 Oncology Venture US, Inc. Miscellaneous Commercial ServicesCommercial Services Oncology Venture US, Inc. develops therapies for cancer treatment. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Director/Board Member Chief Executive Officer | |
| Medical Prognosis Institute, Inc. | Chairman Director/Board Member Chief Executive Officer | ||
| University of Copenhagen | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Chairman Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Contera Pharma ApS
 Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Contera Pharma ApS is a holding company that identifies and develops treatments for patients suffering from movement disorders. It develops drug candidates based on a combination of repositioning, combinations, and reformulations. The firm's lead project JM-010 is for treatment of dyskinesia associated with Parkinson's disease. It develops an approach of using a combination therapy to tackle clinically relevant synergistic pathways to obtain therapeutic effects which will generate efficacious therapeutic entities based on robust pre-clinical and clinical evidence. The company was founded by Mikael Søndergaard Thomsen and John Bondo Hansen in 2010 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Acesion Pharma ApS
 Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Liplasome Pharma ApS
 Liplasome Pharma ApS Pharmaceuticals: MajorHealth Technology Liplasome Pharma ApS operates as a biotech company focusing on oncology. It develops drug delivery technologies for anticancer market. The firm's drug delivery platform consists of a lipid based drug delivery system for the intravenous transportation of anticancer drugs and prodrugs. The company was founded in 2002 and is headquartered in Hoersholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| Buhl Krone Holding ApS | Corporate Officer/Principal Chief Executive Officer | ||
| BIOSERGEN AB | Biotechnology | Director/Board Member Director of Finance/CFO | |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| INITIATOR PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Chairman | |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ALK-ABELLÓ A/S | Biotechnology | Director/Board Member | |
| Technical University of Denmark | College/University | Corporate Officer/Principal | |
| Mpi Holding ApS | Corporate Officer/Principal | ||
| Dwork Webdesign | Corporate Officer/Principal | ||
| NUPATHE INC | Medical Specialties | Chief Operating Officer | |
Blue Ocean Robotics ApS
 Blue Ocean Robotics ApS Industrial MachineryProducer Manufacturing Blue Ocean Robotics ApS develops and introduces market-ready robots for industry, healthcare, education, agriculture and construction. The company was founded by Claus Risager and is headquartered in Odense, Denmark. | Industrial Machinery | Corporate Officer/Principal | |
SSP Technology A/S
 SSP Technology A/S Electrical ProductsProducer Manufacturing SSP Technology A/S designs, develops, and optimizes wind turbine blades. Its product range embraces wind turbine blade technology, mould manufacture, and blade development. The company was founded by Rune Schytt-Nielsen and Flemming Sørensen in 2001 and is headquartered in Stenstrup, Denmark. | Electrical Products | Human Resources Officer | |
| Bjørn Svendsen København A/S | Director/Board Member | ||
| CESSATECH A/S | Pharmaceuticals: Major | Chairman | |
| University of Southern Denmark | College/University | Undergraduate Degree | |
BioNumerik Pharmaceuticals, Inc.
 BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology BioNumerik Pharmaceuticals, Inc. discovers and develops new medicines for cancer treatment. The firm's products include Tavocept which has the potential to substantially increase patient survival in the most common type of lung cancer and possibly many other forms of cancer, and Karenitecin which is an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company was founded by Frederick H. Hausheer on December 15, 1992 and is headquartered in San Antonio, TX. | Pharmaceuticals: Major | Director/Board Member | |
| West Chester University of Pennsylvania | College/University | Undergraduate Degree | |
| Drexel University | College/University | Masters Business Admin | |
CMO Council
 CMO Council Miscellaneous Commercial ServicesCommercial Services CMO Council is a network of executives dedicated to high-level knowledge exchange, thought leadership, and relationship building among senior corporate marketing leaders. The private company is based in Palo Alto, CA, and was founded by Donovan Neale-May. The company provides insights and best practices on various marketing topics, including AI, customer experience, revenue growth, and digital transformation. The company also explore the impact of the pandemic on traditional retailers and the need for agility in recovering from it. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Ontario Institute for Cancer Research
 Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Hospital/Nursing Management | Chairman | |
GE Healthcare, Inc.
 GE Healthcare, Inc. Medical SpecialtiesHealth Technology GE Healthcare, Inc. manufactures and distributes diagnostic imaging agents and radiopharmaceuticals for imaging modalities that are used in medical imaging procedures. It offers dyes that are used in magnetic-resonance-imaging procedures. The firm also manufactures medical diagnostic equipment including CT image machines. It develops healthcare technological solutions for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery and biopharmaceutical manufacturing. The company was founded in 1994 and is headquartered in Princeton, NJ. | Medical Specialties | Sales & Marketing | |
| Injecto A/S | Chairman | ||
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
| American College of Obstetricians & Gynecologists | Corporate Officer/Principal | ||
Conrig Pharma ApS
 Conrig Pharma ApS Pharmaceuticals: MajorHealth Technology Conrig Pharma ApS provides drug for oral treatment of atopical disease. Its new drug (CRG-010) is use for topical treatment of itch/pruritus associated with atopical dermatitis. The company was founded by John Bondo Hansen and Mikael Sondergaard Thomsen on December 20, 2010 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
| Galecto Biotech AB | Chairman | ||
Eir Ventures Partners AB
 Eir Ventures Partners AB Investment ManagersFinance Eir Ventures Partners AB (Eir Ventures) is an independent venture capital firm founded in 2020 by Dr Magnus Persson, Dr Stephan Christgau, Andreas Segerros and Dr Amanda Hayward. The firm is headquartered in Stockholm with an additional office in Copenhagen, Denmark. | Investment Managers | Chairman | |
| P O Persson i Lidingö AB | Director/Board Member | ||
| Duomedix AB | Corporate Officer/Principal | ||
| Merigen AB | Corporate Officer/Principal | ||
| Sls Ventures AB | Director/Board Member | ||
Glycom A/S
 Glycom A/S BiotechnologyHealth Technology Glycom A/S engages in the development, synthesis, and commercialization of human milk oligosaccharides. It develops chemical and enzymatic technologies for synthesis of human milk oligosaccharide powders. The company was founded by Gyuala Dekany, Mark von Itzstein, Joachim Erich Thiem, Arnold Stutz, and Inge Lundt on March 22, 2005 and is headquartered in Horsholm, Denmark. | Biotechnology | Director of Finance/CFO | |
| The European Commission | General Government | Corporate Officer/Principal | |
Teknologisk Institut
 Teknologisk Institut Miscellaneous Commercial ServicesCommercial Services Teknologisk Institut develops, applies, and disseminates research- and technology-based knowledge for the Danish business. It is an independent, non-profit institution that provides training courses and conferences including information technology courses; energy and construction; project; personal development; leadership; productivity, measuring technology, and logistics; quality; food and environment; communication; sales and marketing; and human resource, law, and economics. In addition, it also carries out consultancy and standardization activities. The firm provides services in business areas such as building and construction; business and industrial development; chemistry and biotechnology; energy and climate; environment, working environment, and health; food and packaging; industrial measurements and control; industrial production and development; meat industry solutions; productivity and management; surfaces and microtechnology; and transport and logistics. The company was founded by Gunnar Gregersen in 1906 and is headquartered in Taastrup, Denmark. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
SEED Capital Management I/S
 SEED Capital Management I/S Investment ManagersFinance SEED Capital Management I/S is an Independent Venture Capital firm founded in 2004. The company is headquartered in Copenhagen, Denmark. | Investment Managers | Private Equity Investor |
Statistiche
Distribuzione geografica
| Danimarca | 26 |
| Stati Uniti | 13 |
| Svezia | 11 |
| Paesi Bassi | 2 |
| Canada | 2 |
Settori
| Health Technology | 21 |
| Consumer Services | 8 |
| Commercial Services | 5 |
| Producer Manufacturing | 3 |
| Health Services | 3 |
Posizioni
| Director/Board Member | 141 |
| Corporate Officer/Principal | 64 |
| Chairman | 44 |
| Independent Dir/Board Member | 39 |
| Chief Executive Officer | 37 |
Contatti più connessi
| Insiders | |
|---|---|
| Gunnar Magnus Modee Persson | 51 |
| Peter Buhl Jensen | 32 |
| Steve Carchedi | 22 |
| Frank Knudsen | 21 |
| Gail Maderis | 20 |
| Duncan Moore | 19 |
| Henrik Kristian Moltke | 16 |
| Robert Oliver | 14 |
| Gerald McLaughlin | 12 |
| Ulla Hald Buhl | 12 |
| Marie Foegh | 12 |
| Claus Frisenberg Pedersen | 11 |
| Jens Knudsen | 10 |
| Niels Laursen | 9 |
| Steen Meier Knudsen | 9 |
- Borsa valori
- Insiders
- Thomas Jensen
- Connessioni Società
